Related by context. All words. (Click for frequent words.) 62 analyst Liana Moussatos 62 Jim Birchenough 61 Pantginis 60 Jason Kolbert 59 David Amsellem 59 Aaron Reames 59 Jonathan Aschoff 58 analyst Geoffrey Meacham 58 analyst Jim Reddoch 58 Yaron Werber 58 Mark Schoenebaum 58 Liana Moussatos 57 Jason Kantor 57 analyst Cory Kasimov 57 Brion Tanous 57 Joel Sendek 57 Edward Tenthoff 57 Moussatos 57 David Molowa 57 Joseph Pantginis 57 Mark Monane 56 analyst Jonathan Aschoff 56 analyst Annabel Samimy 55 Eric Ende 55 Jed Dorsheimer 55 analyst Jim Birchenough 55 analyst Amit Hazan 55 Annabel Samimy 55 Keay Nakae 55 Mintz Levin Represents 55 Geoffrey Meacham 54 Sam Fazeli 54 analyst Bruce Nudell 53 Cory Kasimov 53 analyst Tim Savageaux 53 Trevor Polischuk 53 analyst Geoffrey Porges 53 analyst Mark Schoenebaum 53 analyst Colby Synesael 53 analyst Jesse Pichel 53 analyst Raj Denhoy 53 Phil Nalbone 52 Ananda Baruah 52 Kochnover 52 analyst Yaron Werber 52 analyst Mark Monane 52 Bret Holley 52 analyst Ken Trbovich 52 analyst Phillip Nalbone 52 Claude Camire 52 analyst Amit Bhalla 52 William Plovanic 52 analyst Kristine Koerber 52 Kalpesh Kapadia 52 analyst Hari Sambasivam 51 Aquilo Partners 51 Tenthoff 51 Leerink Swan 51 analyst Simos Simeonidis 51 Ronny Gal 51 Jami Rubin 51 NASDAQ TWPG 51 Robyn Karnauskas 51 Steven Harr 51 Glenn Reicin 51 Doug Sipkin 51 analyst Lawrence Keusch 51 Gbola Amusa 51 Chris Shibutani 51 Jon Lecroy 51 Geoff Porges 50 JoAnne Feeney 50 Geoff Meacham 50 Walter Nasdeo 50 Simos Simeonidis 50 Navdeep Jaikaria 50 Stelios Papadopoulos 50 analyst Glenn Novarro 50 Joshua Schimmer 50 Matt Miksic 50 Avik Roy 50 Ian Somaiya 50 Denhoy 50 Lawrence Biegelsen 50 Rajesh Ghai 50 Sven Borho partner 50 Analyst Dick Bove 50 Dr. Jim Birchenough 49 Karen Boodram 49 Simeonidis 49 Sven Borho 49 Akhtar Samad 49 Molowa 49 Satya Chillara 49 analyst Joanne Wuensch 49 analyst Gbola Amusa 49 analyst Alexandra Hauber 49 Swiss brokerage Helvea 49 Amir Rozwadowski 49 analyst Tore Svanberg 49 analyst Rommel Dionisio 49 Joanna Makris 48 Roger Longman 48 analyst Shebly Seyrafi 48 Steve Massocca 48 Aberman 48 Rampertab 48 analyst Randall Stanicky 48 analyst Tim Klasell 48 Leerink analyst 48 analyst Maged Shenouda 48 Ben Mogil 48 Unterberg Towbin 48 George Grofik 48 Joanne Wuensch 48 Cannacord Adams 48 Hamed Khorsand 48 Eyetech Pharmaceuticals 48 Greg Geissman 48 analyst Lasan Johong 48 Seattle Genetics SGEN 48 Biomarin 48 analyst Walter Piecyk 48 Sumit Malhotra 48 Larry Biegelsen 48 analyst Bruce Cranna 48 Xenoport Inc. 48 Monane 48 Resumes Coverage 47 Raj Denhoy 47 analyst Sapna Srivastava 47 Nasdaq GPRO announced 47 Michael Leuchten 47 analyst Omotayo Okusanya 47 Biogen NASDAQ BIIB 47 Lawrence Keusch 47 analyst Christa Quarles 47 Vik Grover 47 economist Ted Wieseman 47 Inc. NASDAQ ITMN 47 CE Unterberg 47 Alexandra Hauber 47 Merriman Curhan Ford 47 Christian Itin 47 ImmunoCellular Therapeutics 47 Morgan Stanely 47 Reiterates Outperform 47 David Turkaly 47 Quynh Pham 47 Reiterates Buy Rating 47 NASDAQ ADLR 47 Kevin Scotcher 47 Olav Zilian 47 Andrew Vaino 47 Atsushi Seki 47 Aderis 47 PDL BioPharma PDLI 47 Mr. Kriegsman 47 Nasdaq IPXL 47 Stifel Nicholaus 47 TNGN 46 Catalyst Biosciences 46 NASDAQ ACOR 46 ThinkEquity Partners LLC 46 Reiterates Hold 46 Favus Institutional Research 46 Alnylam Pharma 46 Horst Hueniken 46 Reiterates Neutral Rating 46 Vincent Mutel CEO 46 Bert Hazlett 46 Cannacord Genuity 46 Jeffrey Frelick 46 Ranjit Kapadia 46 Maxcor Financial 46 Orbimed 46 ThinkEquity LLC 46 Sanjay Shrestha 46 MOGN 46 analyst George Grofik 46 Deane Dray 46 Suraj Kalia 46 ThinkEquity 46 analyst Gurinder Kalra 46 Broadpoint Capital 46 Analysts Initiate Coverage 46 PDL Biopharma 46 Bayhill Therapeutics 46 Duane Grubert 46 EdgeWater Research Partners 46 TooNiceStocks 46 analyst Junaid Husain 46 Assumes Coverage 46 Maraganore 46 analyst Patrick Walravens 46 TSRX 46 Kin Ho 46 Auriga USA 46 Christopher Danely 46 analyst Ashwin Shirvaikar 46 Jefferies JEF 46 Daniel Meron 46 Steven Kriegsman 46 Romit Shah 46 Opko 45 Jonathan Dorsheimer 45 MacMurray Whale 45 Orbimed Advisors LLC 45 Kash Rangan 45 Eric Martinuzzi 45 Geoffrey Porges 45 Jay Vleeschhouwer 45 Philip Alling 45 IDEV 45 Paul Mansky 45 Capstone Investments 45 Piper Jaffray PJC 45 LifeTech Capital 45 analyst Edward Sterck 45 Jim Reddoch 45 Carl Seiden 45 Ardour Capital Investments 45 Yakatan 45 Neostem 45 Inc. Nasdaq ABGX 45 analyst Edlain Rodriguez 45 Achillion Pharmaceuticals 45 analyst Jeff Fidacaro 45 Sara Michelmore 45 Lazard Capital 45 Leerink 45 Healthcare Conf 45 JSB Partners 45 Nick Majendie 45 analyst Erik Suppiger 45 Ardour Capital 45 Alnylam Nasdaq ALNY 45 Jeremy Sussman 45 Dominic Valder 45 Fulcrum Global 45 Darren Aftahi 45 Saftlas 45 analyst Ajit Pai 45 OPTR 45 Schoenebaum 45 analyst Benjamin Mogil 45 Healthcare Tailwinds Conference 45 Roopesh Patel 45 OGXI 45 analyst Robert Cihra 45 Creditsights 45 CapStone Investments 45 analyst Mario Mendonca 44 Noah Beerman 44 Gets Downgraded 44 analyst Dinesh Moorjani 44 Isis Pharma 44 Myriad Genetics Inc 44 SSRX 44 Frederick Searby 44 Richard Fetyko 44 Nasdaq AVNR 44 analyst Jami Rubin 44 Bruce Nudell 44 Celgene CELG 44 analyst Julio Quinteros 44 Jay Deahna 44 Douglas Sipkin 44 Piper Jaffrey 44 Mohammad Azab MD 44 Rigel Pharmaceuticals 44 analyst Ross Muken 44 Claudia Shank Hueston 44 Ed Groshans 44 Dolat Capital Market 44 Andrew Uprichard 44 Khandaker Partners 44 ThinkEquity downgraded 44 analyst Mehdi Hosseini 44 Jerry Doctrow 44 analyst Emme Kozloff 44 CanaccordAdams 44 analyst Andrew Goodsall 44 Joshua Raskin 44 Company Report companiesandmarkets.com 44 Cyclacel Pharmaceuticals 44 Leerink Swann 44 Prashant Nair 44 Atif Malik 44 Initiate Coverage 44 DRRX 44 Acorda Therapeutics ACOR 44 Vishal Shreedhar 44 CardioVascular BioTherapeutics 44 Cantor Fitzgerald reiterates 44 Ajit Pai 44 Sandler O'Neill Partners LP 44 Ambrish Srivastava 44 Amit Daryanani 44 Silviu Itescu 44 Orbimed Advisors 44 Acrux Limited 44 Isis Pharmaceuticals ISIS 44 Liisa Bayko 44 Christa Quarles 44 Sara Elford 44 Maintains Buy 44 Randal Konik 44 Christa Sober 44 Daniel Fannon 44 analyst Jeffrey Zekauskas 44 Harry Palmin President 44 Safi Bahcall Ph.D. 44 Rating Maintained 44 analyst Bijan Moazami 44 Emisphere Technologies 44 Rich Repetto 44 Brian Bapty 43 Fidelity Biosciences 43 Brean Murray 43 Bernd Seizinger 43 ThinkPanmure 43 Joe Giamichael 43 Suntrust Robinson Humphrey 43 Bhavin Shah 43 Clarus Securities 43 Ursaner 43 Initiating Coverage 43 ANALYST TAKE JPMorgan 43 Ken Trbovich 43 Nasdaq MOGN 43 Analyst Cody Acree 43 analyst Jeffrey Fidacaro 43 Idera Pharmaceuticals 43 CorporateCommunications +#-#-#-# 43 Ardea Biosciences 43 GARP Research 43 analyst Amit Daryanani 43 Kenneth Zaslow 43 MultiCell Technologies 43 Vertex Pharmaceuticals Nasdaq VRTX 43 Reiterates Hold Rating 43 Kaufman Bros 43 Glenn Novarro 43 Carl Kirst 43 Steven Burakoff 43 Anton Wahlman 43 analyst Ghansham Panjabi 43 RBC Capital Mkts Reiterate 43 Isaac Ro 43 Cannacord 43 Maintains Hold 43 Girish Tyagi 43 analyst Jonathan Schildkraut 43 Cormac Leech 43 Kirk Materne 43 MolMed 43 Jesse Pichel 43 Bruce Cranna 43 Reiterates Buy 43 Tony Lesiak 43 Wendell Zerb 43 analyst Kurt Hallead 43 Sterling Auty 43 Nollenberger Capital 43 Jon Arfstrom 43 analyst Sterling Auty 43 SGXP 43 Nasdaq IDIX 43 Dr. Damaj 43 Morgan Joseph TriArtisan 43 analyst Tero Weckroth 43 Timothy Arcuri 43 analyst Vijay Jayant 43 Ken Cacciatore 43 Yoshihiko Hatanaka 43 Gary Nachman 43 Shai Gozani 43 Alton Boynton 43 Dave Rovelli 43 Dwight Brunoehler 43 Synta Pharmaceuticals 43 Adrian Hobden Ph.D. 43 NASDAQ CYPB 43 Neurobiological Technologies 43 Clay Siegall 43 analyst Romit Shah 43 analyst Nigel Dally 43 Punk Ziegel 43 Dale Pfost 43 Kirsten Drejer 43 Nasdaq ZIOP 43 Reiterate Buy rating 43 RBC NYSE RY 43 Canaccord Genuity 43 Jeffrey Bencik 43 Mihael Polymeropoulos 43 Apricus Biosciences 43 Jon LeCroy 43 BAML 43 Vertex Pharmaceuticals NASDAQ VRTX 43 Ariad Pharmaceuticals 43 analyst Mahesh Sanganeria 43 James Manuso 43 analyst Andrey Glukhov 43 Cambria Biosciences 43 Ambrian Partners 42 Coverage Initiated 42 RDEA 42 Daniel Junius 42 IDIX 42 BMRN 42 Genzyme Nasdaq GENZ 42 Gilead Sciences GILD 42 Frozen Shoulder syndrome 42 BGB Securities 42 Brigantine Advisors 42 BAS ML 42 TriPoint Global Research 42 Unicon Investment 42 Enzon Pharmaceuticals ENZN 42 Edlain Rodriguez 42 analyst Robyn Karnauskas 42 Andreas Theisen 42 Jeffrey Holford 42 Potelligent Technology 42 Lee Fensterstock Chairman 42 BiolineRX 42 Brock Vandervliet 42 Harry Glorikian 42 analyst Elizabeth Osur 42 Matthew Heimermann 42 Phil Skolnick 42 Zavoico 42 reaffirmed Outperform rating 42 CE Unterberg Towbin 42 Chiral Quest 42 ImmunoGen IMGN 42 PiperJaffray analyst 42 analyst Edmo Chagas 42 Jefferies Broadview 42 Valeant Pharma 42 Merriman Curhan 42 Jonathan Hykawy 42 John DiFucci 42 Paul Cuddon 42 analyst Jason Napodano 42 Flemming Ornskov 42 Garo Toomajanian 42 Reiterates Strong 42 Philippe Archinard 42 BioRexis 42 Pathway Diagnostics 42 Shiv Kapoor 42 analyst Kemp Dolliver 42 MEDACorp 42 Nicholas Aberle 42 Ross Muken 42 +#-#-#-# @ russopartnersllc.com 42 Darren Lehrich 42 Vineet Bhatnagar 42 analyst Chad Friess 42 Drickamer 42 Brent Thill 42 analyst Laurent Horrut 42 Daniel Berenbaum 42 analyst Jacques Rousseau 42 Kemp Dolliver 42 Ph.D. Targacept 42 BernsteinResearch 42 Carla Antunes da Silva 42 QLTI 42 Vaccinex 42 Stanicky 42 Piper Jaffray 42 Nicholas Landekic 42 Maintains Neutral 42 Kenji Masuzoe 42 Inc SPPI 42 Trimeris TRMS 42 Richard Slape 42 analyst Shaul Eyal 42 Aloprim 42 Geoff Ruddell 42 Camvia 42 Lexicon Pharmaceuticals 42 Edward Ditmire analyst 42 Faisel Khan 42 VisEn Medical 42 Biophan Technologies 42 Ulrich Dauer CEO 42 PDL BioPharma Inc 42 Remi Barbier 42 Wolfgang Renner 42 Ron Bentsur 42 analyst Alex Gauna 42 analyst Albert Savastano 42 Integra LifeSciences IART 41 WR Hambrecht 41 Benjamin Mogil 41 Katy Huberty 41 Kuni Chen 41 Grasher 41 analyst Mark Wienkes 41 Thoratec Presentation 41 Gilead Sciences NASDAQ GILD 41 Mats Nystrom 41 WR Hambrecht + 41 ECTE 41 Nasdaq ANDS 41 ACADIA Pharmaceuticals 41 analsyt 41 Jerry Newmin 41 BioMarin Pharmaceutical 41 Enzo Therapeutics 41 Taglich Brothers 41 NASDAQ SLXP 41 Nicholas Galakatos 41 Sav Neophytou 41 Arnie Berman 41 Drew Fromkin President 41 Pat Walravens 41 Kristine Koerber 41 Natasha Boyden 41 analyst Satya Chillara 41 Analysts Begin Coverage 41 United Therapeutics UTHR 41 Fixed Income Strategist 41 analyst Chandan Sarkar 41 analyst Gil Luria 41 Jason Gurda 41 NASDAQ MYGN 41 Genelabs Technologies 41 analyst Randy Ollenberger 41 analyst Allan Mishan 41 IDBI Capital Markets 41 analyst Lori Appelbaum 41 Mark Pykett 41 ANALYST TAKE Bear Stearns 41 Infinity Pharmaceuticals 41 ProMune 41 Speculative Buy recommendation 41 Analyst Rebecca Arbogast 41 Durect Corporation 41 Tao Levy 41 Abbie Celniker Ph.D. 41 Eric Kainer 41 Finncap 41 FTN Equity 41 Suneet Kamath 41 analyst Peter Misek 41 QLT QLTI 41 analyst Chris Umiastowski 41 CancerVax Corporation 41 James Kumpel 41 Cabilly patent 41 Chardan Capital Markets 41 Matthew Sheerin 41 ISIS Pharmaceuticals 41 AMAG Pharma 41 Feltl 41 ISTO 41 Chris Umiastowski 41 ALXA 41 TransMolecular 41 MyVax 41 Canaccord Adams 41 Centient Biotech Investor 41 Meredith Adler 41 Jordan Estra 41 analyst Onno Rutten 41 NASDAQ ERES 41 analyst Ananda Baruah 41 Nominated Advisor 41 strategist Brian Belski 41 Paul Laikind 41 CapStone 41 Elazar Rabbani 41 NuVasive NUVA 41 Immucor BLUD 41 Todd Bault 41 Amorcyte 41 NASDAQ MELA 41 Anindya Mohinta 41 analyst Charles Boorady 41 Stylli 41 Peer Perform rating 41 Ulrich Grau Ph.D. 41 Christopher Horvers 41 Idenix Pharmaceuticals Inc. 41 Arvind Sood 41 Charles Strauzer 41 brokerage Helvea 41 Alain Karaoglan 41 Brian Piccioni 41 Spirogen 41 strategist Tony Crescenzi 41 Oppenheimer OPY 41 Igor Gonda 41 Rating Reiterated 41 Taglich 41 AmTech Research 41 Inc. NASDAQ HGSI 41 Alastair Riddell 41 analyst Hisashi Moriyama 41 Tellabs Presentation 41 CEO Manny Tsoupanarias 41 RenaMed 40 Orest Wowkodaw 40 Michael Vinciquerra 40 Wedbush 40 Charles Minervino 40 Tim Klasell 40 Brigantine Advisors analyst 40 Donald Fandetti 40 Gord Currie 40 Louise Makin 40 Natixis Bleichroeder analyst 40 Randall Stanicky 40 Piper Jaffray nyse PJC 40 Samuel Waksal pleaded guilty 40 Anadys Pharmaceuticals 40 Uche Orji 40 Tacere 40 HC Wainwright 40 Inc. NASDAQ EVVV 40 Bruce Harting 40 Barclays Capital Reiterate Overweight 40 Steve Sakwa 40 BioMarin Pharma 40 Dan Passeri 40 Joe Osha 40 Helene Wolk 40 Lonnie Moulder 40 Immunex Corporation 40 Drew Brosseau 40 Durect 40 Mike Krensavage 40 analyst Douglas Sipkin 40 Altus Pharmaceuticals 40 Broker Dresdner Kleinwort 40 Neogenix 40 Donald Drakeman 40 Immunosyn 40 Craig Hallum 40 Adam Barkstrom 40 Jon Gencher 40 Rhein Biotech GmbH 40 Conatus Pharmaceuticals 40 Seventh Annual JMP 40 Matthew Fassler 40 Segrich 40 RODM 40 newratings.com Analyst Kurt Hallead 40 Joseph Amaturo 40 GSCO 40 Marillion Pharmaceuticals 40 MYGN 40 Jonathan Vyorst 40 Klaus Schollmeier 40 Kevin Rakin 40 strategist Marc Pado 40 SoundView Technology 40 Greg Wujek 40 Stephen Tusa 40 Betsy Van Hees 40 Funtleyder 40 Oncogenex 40 Patrice Milos 40 Sector Performer rating 40 Don deBethizy 40 Hanson Westhouse 40 Charles Boorady 40 Mark Bacurin 40 Pluristem Therapeutics 40 Bibicoff + MacInnis 40 Undiscovered Equities 40 analyst Daniel Shteyn 40 Eun K. 40 James McIlree 40 Drew Fromkin 40 analyst Peter Rhamey 40 Ken Hoexter 40 Optimer Pharmaceuticals 40 FLML 40 Girish Nadkarni 40 Des Kilalea 40 Barry Labinger 40 Hank Calenti 40 Conviction Sell 40 Tianyin Pharmaceutical 40 Nps Pharmaceuticals Incorporated 40 Santhera Pharmaceuticals 40 Doliveux 40 Yasuhiro Nakazawa 40 RBC Capital NYSE RY 40 Stromedix 40 analyst Vishal Shreedhar 40 Pharmacueticals 40 Human Genome Sciences HGSI 40 OIIM 40 Oscar Gruss 40 INFI 40 Endo Pharmaceuticals ENDP 40 John Kartsonas 40 Scot Ciccarelli 40 Andy Kaplowitz 40 Auriga 40 analyst Maher Yaghi 40 Surajit Pal 40 Michael Rehaut 40 Professor Silviu Itescu 40 ZLCS 40 Matt Nemer 40 Memet Kont 40 Ajay Kejriwal 40 Stifel Nicholas 40 Deepak Chhabria 40 Nasdaq NPSP 39 Randy Binner 39 Leerink Swann LLC 39 George Scangos 39 Eran Broshy 39 Edwin Groshans 39 Auxilium Pharma 39 Analyst Toni Sacconaghi 39 CONTACT ICR 39 LMAT 39 Nasdaq ADLR 39 JMP Securities LLC 39 Tobinick 39 told BioWorld Today 39 Gene Munster Piper Jaffray 39 Dees PhD 39 Sol Barer 39 Cochran Caronia 39 Gerard Klauer Mattison 39 NASDAQ NOVA 39 BWS Financial 39 analyst Sanjay Vidyarthi 39 Kelly Luethje #-#-# 39 Vincent Milano ViroPharma 39 Equal Weight rating 39 Nessuah Zannex 39 Jay Srivatsa 39 Achillion Pharmaceuticals Inc 39 Nancy Wysenski 39 Philip S. Pesin 39 QGEN 39 Somesh Sharma 39 BioMedTracker 39 NEOP 39 Submits Response 39 Broadpoint Amtech 39 Shriram Iyer 39 Putnam Lovell NBF 39 Lisa Krinsky 39 analyst Dan Wantrobski 39 Mark Edelstone 39 analyst Ambrish Srivastava 39 Navid Malik 39 Nicholas Landekic President 39 Nitsan Hargil 39 analyst Anthony Chukumba 39 Joseph Greff 39 Amylin AMLN 39 Stuart Muter 39 hematologic oncology 39 Pacific Growth Equities 39 HealthCor 39 Stieven 39 Metaphore 39 Poordad 39 analyst Frank Mitsch 39 Westwind Partners 39 Lars Ekman 39 Robert Cihra 39 Neely Tamminga 39 analyst Jason Gurda 39 Stanley Crooke 39 Psivida 39 ZymoGenetics ZGEN 39 Dhulsini de Zoysa 39 Natexis Bleichroeder analyst 39 BioWorld International 39 Feltl & 39 KIM ENG 39 Nextech Venture 39 Wunderlich Securities 39 Regeneron Pharma 39 Orville Kolterman 39 BPSG 39 Impax Laboratories IPXL 39 Underweight rating 39 economist Joachim Fels 39 Dr. Michelle Berrey 39 analyst Rebecca Runkle 39 Cormark Securities 39 Callisto Pharmaceuticals 39 http:/www.sunesis.com 39 NYSE Amex OPK 39 Bianco MD 39 Oppenheimer NYSE OPY 39 ANALYST TAKE Stifel Nicolaus 39 analyst Randy Binner 39 Emkay Global 39 Inc. Nasdaq AFFY 39 Bioservices 39 analyst Eileen Furukawa 39 Ehud Gelblum 39 Incyte INCY 39 antibacterial therapeutics 39 Caroline Loewy 39 Carl Spana 39 strategist Subodh Kumar 39 Paul Averback 39 Reiterates Sell 39 Celgene NASDAQ CELG 39 Amit Hazan 39 RF Micro Device 39 Kotak Institutional Equities 39 Balyasny Asset Management 39 Nathan Schneiderman 39 Brean Murray upgrades 39 Psyadon 39 FBR Capital NASDAQ FBCM 39 NASDAQ AUXL 39 Kauffman MD Ph.D. 39 Helvea analyst Olav Zilian 39 Biogen Nasdaq BIIB 39 Jeffrey Buchalter 39 Joseph Rubinfeld 39 Rouhandeh 39 Mahesh Sanganeria 39 Overweight Rating 39 Paul Adornato 39 Immunomedics 39 Mr. Zami Aberman 39 Piper Jaffray downgraded 39 Ahmar Zaman 39 Ehrenkrantz King Nussbaum 39 Westrock Advisors 39 Ramesh Misra 39 Vertex Pharmaceuticals VRTX 39 Inc CEPH 39 Joseph Teklits 39 Demopulos 39 Carol Werther 39 Steven Halper 39 Tore Svanberg 39 analyst Sumit Malhotra 39 Cortria 39 Julian Callow economist 39 Lixte 39 Richard Kugele 39 Marc Cluzel 39 C. Bernstein 39 Daniel M. Skovronsky 39 Dushan Batrovic 39 Douglas Harned 39 Metamark 38 analyst Raghu Hariharan 38 LifeSci Advisors 38 analyst Larry Biegelsen 38 Dr. Ogan Gurel 38 NEUTRAL rating 38 Drakeman 38 analyst Julian Easthope 38 Venkat Jasti 38 Reiterates Buy rating 38 Broker Investec 38 Lauren Cooks Levitan 38 analyst Aldo Mazzaferro 38 A. Leerink 38 Ambrian Partners Limited 38 Martin Nicklasson CEO 38 Gregory Drahuschak 38 Zeneus Holdings 38 analyst Justin Yagerman 38 Baxter NYSE BAX 38 Patrick Fourteau 38 Kevin Ellich 38 WuXi PharmaTech WX 38 JMP Securities 38 Dahlman Rose downgraded 38 analyst Robert Drbul 38 Rachael Rothman 38 InNexus Biotechnology 38 Sven Andreasson 38 Sonenshine Partners 38 Cypress Bioscience 38 Solasia 38 Encysive Pharmaceuticals 38 Tom Cholnoky 38 analyst Srini Pajjuri 38 #.#x #E [001] 38 Gerry Hennigan 38 Gridstone 38 Tahira Afzal 38 Manishi Raychaudhuri 38 Rob Cihra 38 Jeff Fidacaro 38 economist Marisa Fassler 38 Critchfield MD 38 QLT.TO 38 Joel Fishbein 38 analyst Leon Esterhuizen 38 Garth Likes 38 Armando Anido 38 Stacy Rasgon 38 Thom Gunderson 38 Mr. Mordock 38 ROTH Capital 38 ThinkEquity upgraded 38 Laboratories Rahway NJ 38 Affymax Inc. 38 Bernard Hanssens 38 Cabilly 38 Shai N. Gozani 38 NeoGenesis 38 analyst Edwin Mok 38 analyst Silke Stegemann 38 Eric Coldwell 38 Galakatos 38 Chris Theal 38 Seshadri Sen 38 analyst Mark Lipacis 38 Rodman Renshaw 38 Dr. Gonenne 38 Karl Heinz Scheunemann 38 Amex KAL 38 Nick Selvaratnam 38 analyst Zaineb Bokhari 38 Nick Galakatos 38 Ron Wortel 38 Mirabaud Securities 38 JP Morgan 38 AEterna Zentaris Inc. 38 analyst Irene Nattel 38 Institutional Equities 38 ANALYST TAKE Merrill Lynch 38 Innovations IMA 38 Craig Woker 38 Poalim Sahar 38 Iris Loew Friedrich 38 Merck MRK Pfizer PFE 38 Garheng Kong 38 Georges Lequime 38 WR Hambrecht analyst 38 JovInvestment 38 Maxine Gowen 38 analyst Glenn Reicin 38 analyst Natasha Boyden 38 Kishor Ostwal 38 JMP Securities downgraded 38 Krensavage 38 Vijay Rakesh 38 Dr. Masamichi Koike 38 Jefferies 38 InterfeRx 38 Donald L. Drakeman 38 OPKO Health 38 Hakan Edstrom 38 Nick Spoliar 38 Azrack 38 Charly Travers 38 spokeswoman Caroline Pecquet 38 Friedman Billings reiterate 38 Pharmanet 38 JM Dutton 38 Wells Fargo Initiates Coverage 38 Overweight rating 38 Neil K. Warma 38 Nasdaq PRXL 38 Aegera 38 Helvea AG 38 Craig Siegenthaler 38 Inc HGSI.O 38 Nasdaq IDRA today 38 Barry D. Quart 38 Plovanic 38 analyst Seamus Fernandez 38 Epizyme 38 Allan Mishan 38 Helvea SA 38 analyst Sasa Zorovic 38 SG Cowen 38 Job Langbroek 38 Simona Jankowski 38 Sommadossi 38 Schwab SoundView 38 NASDAQ ARIA 38 PharmaFrontiers 38 Lilladher 38 Reddoch 38 Anurag Rana 38 June Almenoff MD 38 Sarah Wharry 38 Yaffa Beck